Firms funding a $1.8 billion biology dataset get to use it first.
Biohub, two US agencies, Google and Meta committed that sum on Wednesday. The money buys measurements of how cells react, at a scale no lab has reached. Everything opens to all researchers later, after the funders have had their turn.
Why it mattersDrug discovery stays slow because nobody can simulate a living cell well enough. A dataset this big decides who builds the first working simulator.
▶ Related video: Priscilla Chan and Mark Zuckerberg: Frontier AI + Virtual Biology To Solve All Diseases
Read in the app — free, in 9 languages
Related stories
A sign error wiped out three of OpenAI's 722 new maths papers.2026-10-08Buterin says AI maths could break crypto before quantum computers do.
2026-10-08AI agents upsold wealthy users who asked for the cheapest option.
2026-10-08OpenAI's machine-checked proof does not match the proof it published.
2026-10-08Nvidia found one training step changes just 1% of a model.
2026-10-07